Margaret M. FitzPatrick - May 5, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Maggie FitzPatrick
Stock symbol
ANTX
Transactions as of
May 5, 2022
Transactions value $
$0
Form type
4
Date filed
5/9/2022, 09:39 PM
Previous filing
Mar 3, 2022
Next filing
May 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANTX Stock Option (right to buy) Award $0 +11.5K $0.00 11.5K May 5, 2022 Common Stock 11.5K $18.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the Option shall vest on a monthly basis over a three-year period as measured from May 5, 2022.